These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 384788)

  • 41. [Use of gramurin in urinary tract infections in children].
    Mikołajczyk W
    Wiad Lek; 1982 Oct; 35(17):1055-8. PubMed ID: 7179974
    [No Abstract]   [Full Text] [Related]  

  • 42. Microbiological and clinical examinations supporting the effectivity of oxolinic acid (Gramurin) in the treatment of acute enterocolitis.
    Bán E; Szalka A
    Ther Hung; 1982; 30(1):35-41. PubMed ID: 6926907
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical evaluation of oxolinic acid in treatment of acute and chronic urinary tract infections.
    Budhraja SN; Perianayagam WJ
    Indian J Med Sci; 1978; 32(11-12):119-22. PubMed ID: 756860
    [No Abstract]   [Full Text] [Related]  

  • 44. [Activity of oxolinic acid in some models of experimental infections in the rodents].
    De Pascale V; Cristallo Dormia L; Craveri F; Lecchini S; Frigo GM; Crema A
    Boll Chim Farm; 1974 Mar; 113(3):165-74. PubMed ID: 4602595
    [No Abstract]   [Full Text] [Related]  

  • 45. [The passage of antibiotics into prostatic secretions: theoretical and experimental study. Apropos of a new urinary antibiotic: oxolinic acid (proceedings)].
    Richard F; Khoury S; Lambert-Zechovsky N; Bingen E; Küss R
    J Urol Nephrol (Paris); 1979 Mar; 85(3):199-206. PubMed ID: 39178
    [No Abstract]   [Full Text] [Related]  

  • 46. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
    Bertolini A; Castelli M; Genedani S; Garuti M
    Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Minimal inhibitory concentration in hospital bacteria].
    Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
    Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
    [No Abstract]   [Full Text] [Related]  

  • 48. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Synergistic properties of quinolinium compounds with broad spectrum antibiotics].
    Piccolomini R; Allocati N; Auriti R; Minelli G
    G Ital Chemioter; 1983; 30(2-3):91-6. PubMed ID: 6677548
    [No Abstract]   [Full Text] [Related]  

  • 50. [Radioprotective properties of oxolinic acid].
    Znamenskiĭ VV; Terekhov AV; Leonova TS; Zherebchenko PG; Iashunskiĭ VG
    Radiobiologiia; 1986; 26(6):812-4. PubMed ID: 3809418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
    Esposito S; Galante D; Pennucci C; Barba D
    Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Radioprotective properties of oxolinic acid during long-term exposure to radiation].
    Pukhov VV; Daniiarov SB
    Radiobiologiia; 1988; 28(2):279-81. PubMed ID: 3363111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro susceptibility comparisons and recommendations for oxolinic acid.
    Klein D; Matsen JM
    Antimicrob Agents Chemother; 1976 Apr; 9(4):649-54. PubMed ID: 1267439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The rational use of antibiotics in general practice.
    Steele TW; Rich GE
    Aust Fam Physician; 1977 May; 6(5):486-95. PubMed ID: 560184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Variations in vitro of the efficacy of quinolones as a function of pH].
    François B; Gille Y; Schmuck N; Assenat H; Adeleine P; Davoine P
    Nephrologie; 1983; 4(6):259-62. PubMed ID: 6669186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
    Thibault M; Koumaré B; Soussy CJ; Duval J
    Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Modifying effect of oxolinic acid on the radiation-induced hemorrhagic syndrome].
    Tartakovskiĭ VN; Pukhov VV
    Radiobiologiia; 1989; 29(2):276-8. PubMed ID: 2717724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacology of oxolinic acid in young dairy calves.
    Ziv G
    Am J Vet Res; 1976 May; 37(5):513-6. PubMed ID: 776048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative study of six quinolone antibacterials (author's transl)].
    Soussy CJ; Thibault M; Kitzis MD; Acar JF; Duval J; Chabbert YA
    Ann Microbiol (Paris); 1977 Jul; 128B(1):19-33. PubMed ID: 907268
    [No Abstract]   [Full Text] [Related]  

  • 60. Oxolinic acid treatment of urinary-tract infections.
    D'Alessio DJ; Olexy VM; Jackson GG
    Antimicrob Agents Chemother (Bethesda); 1967; 7():490-6. PubMed ID: 5596179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.